investordatabase.org

SCI Ventures

sciventures.com Direct investor

SCI Ventures is a specialist venture fund that invests in early-stage companies developing cures and treatments for paralysis, starting with spinal cord injury. It is backed by leading scientific foundations and clinical centers.

SCI Ventures is a venture capital firm headquartered in London, United Kingdom. It invests directly in companies, from seed to Series B, in paralysis, spinal cord injury, biotech and neuroscience. 9 portfolio companies, as it reports.

“We invest globally in companies with the greatest potential to impact our mission, typically at the Seed - Series B stages.”

— SCI Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series B
Headquarters
London, United Kingdom
Invests in
global
Sectors
paralysis, spinal cord injury, biotech, neuroscience, gene therapy, small molecule drugs, brain-computer interface, electrical stimulation
Portfolio
9 companies
How to reach it
Its contact page on its own site

Team, as SCI Ventures publishes it

  • Adrien Cohen Founding Managing Director, Board & Investment Committee Member
  • Roman Rothaermel, PhD Investment Principal Biotech Operator, PhD Neuroscience University of Oxford
  • Ian Curtis Board Member, ISRT and Reeve Foundation Chairman, HPC plc, Former PwC Partner
  • Tom Londres Board Member, Reeve Foundation CEO, Metro Commercial, Inc.
  • Deborah Backus, PhD Vice President Research & Innovation, Shepherd Center, Director of Virginia C. Crawford Research Institute
  • Peter Luckeneder Global CFO Wings for Life
  • Jean Baptiste Wautier Chair of Investment Committee Ex Chief Investment Officer BC Partners
  • Willie Watt Chair of the Scottish National Investment Bank Ex Managing Director 3i
  • Kiran Dallenbach, PhD Partner at Biomed VC Life Science VC PhD, ETH Zürich
  • Eric Persson Vice Chair Promobilia Foundation Ex CEO of Novax & leading positions at Axel Johnson/Nordstjernan
  • Fotis Hasiotis Ex Managing Director Jefferies, Lazard, Merrill Lynch Ex Global Co-Head of Financial Sponsors
  • Murray Blackmore, PhD Professor Marquette University Leader in nerve regeneration & genetic control

Names and roles exactly as listed on sciventures.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 25 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

and 15 more — the graph.

Where this comes from

Every fact above was read from a page SCI Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 11063 · added 2026-09-29 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under